1. Accueil
  2. Isabelle Desombere
  3. Isabelle Desombere

Onglets principaux

Rechercher
Limit to
Exporter 73 resultats:
Filtres: Auteur is I Desombere
2022
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients., Baron, Frédéric, Canti Lorenzo, and Beguin Yves , Front Immunol, 2022, Volume 13, (2022)
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors., Konnova, Angelina, De Winter Fien H. R., Akshita Gupta, Hotterbeekx An, Berkell Matilda, and Kumar-Singh Samir , Front Immunol, 2022, Volume 13, (2022)
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsBackgroundMethodsResultsConclusionDataSheet_1.docx, Konnova, Angelina, De Winter Fien H. R., Akshita Gupta, Verbruggen Lise, Hotterbeekx An, Berkell Matilda, Teuwen Laure-Anne, Vanhoutte Greetje, Peeters Bart, Raats Silke, et al. , Frontiers in Immunology, Oct-12-2023, Volume 13, (2022)
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol, Adriaenssens, Niels, Scholtes Beatrice, Bruyndonckx Robin, Verbakel Jan Y., De Sutter An, Heytens Stefan, Van Den Bruel Ann, Desombere I, Van Damme Pierre, Goossens Herman, et al. , BMJ Open, Jul-01-2024, Volume 12, Issue 1, (2022)
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol., Adriaenssens, Niels , BMJ Open, 2022 Jan 31, Volume 12, Issue 1, (2022)
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up, Adriaenssens, Niels, Scholtes Beatrice, Bruyndonckx Robin, Van Ngoc Pauline, Verbakel Jan Yvan Jos, De Sutter An, Heytens Stefan, Van Den Bruel Ann, Desombere I, Van Damme Pierre, et al. , BMJ Open, Jul-09-2023, Volume 12, Issue 9, (2022)
Prevalence and incidence of antibodies against SARS-CoV-2 in children and school staff measured between December 2020 and December 2021: Findings of the fifth testing period – brief summary, Merckx, Joanna, Roelants Mathieu, Callies Milena, Desombere I, Kabouche Ines, and Duysburgh Els , (2022)
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up., Adriaenssens, Niels , BMJ Open, 2022 Sep 19, Volume 12, Issue 9, (2022)
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study., Leclercq, V, Van den Houte Nayema, Gisle Lydia, Roukaerts Inge, Barbezange Cyril, Desombere I, Duysburgh Els, and Van der Heyden Johan , Viruses, 2022 04 28, Volume 14, Issue 5, (2022)
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study, Leclercq, V, Van den Houte Nayema, Gisle Lydia, Roukaerts Inge, Barbezange Cyril, Desombere I, Duysburgh Els, and Van der Heyden Johan , Viruses, Jan-05-2022, Volume 14, Issue 5, (2022)
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial, Pannus, Pieter, Depickère Stéphanie, Kemlin Delphine, Houben Sarah, Neven Kristof Y., Heyndrickx Leo, Michiels Johan, Willems Elisabeth, De Craeye Stéphane, Francotte Antoine, et al. , PLOS Global Public Health, Dec-20-2022, Volume 2, Issue 12, (2022)
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant., Ariën, Kevin K. , NPJ Vaccines, 2022 Mar 08, Volume 7, Issue 1, (2022)
2021
Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission., Boey, Lise, Roelants Mathieu, Merckx Joanna, Hens Niel, Desombere I, Duysburgh Els, and Vandermeulen Corinne , Eur J Pediatr, 2021 Aug 28, (2021)
Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries., Berbers, Guy , Nat Commun, 2021 May 17, Volume 12, Issue 1, (2021)
Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay, Mariën, Joachim, Ceulemans Ann, Michiels Johan, Heyndrickx Leo, Kerkhof Karen, Foque Nikki, Widdowson Marc-Alain, Mortgat Laure, Duysburgh Els, Desombere I, et al. , Journal of Virological Methods, Jan-02-2021, Volume 288, (2021)
Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay., Mariën, Joachim , J Virol Methods, 2021 Feb, Volume 288, (2021)
Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide., Vanderheijden, Nathalie, Stevaert Annelies, Jiexiong Xie, Ren Xiaolei, Barbezange Cyril, Noppen Sam, Desombere I, Verhasselt Bruno, Geldhof Peter, Vereecke Nick, et al. , Front Immunol, 2021, Volume 12, (2021)
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2., Triest, David, Geebelen Laurence, De Pauw Robby, De Craeye Stéphane, Vodolazkaia Alexandra, Verbrugghe Mathieu, Magerman Koen, Robben Lara-Lauren, Pannus Pieter, Neven Kristof, et al. , J Clin Virol, 2021 09, Volume 142, (2021)
Persistence of IgG response to SARS-CoV-2, Duysburgh, Els, Mortgat Laure, Barbezange Cyril, Dierick Katelijne, Fischer Nathalie, Heyndrickx Leo, Hutse Veronik, Thomas Isabelle, Van Gucht Steven, Vuylsteke Bea, et al. , The Lancet Infectious Diseases, Jan-02-2021, Volume 21, Issue 2, (2021)
Persistence of IgG response to SARS-CoV-2., Duysburgh, Els, Mortgat Laure, Barbezange Cyril, Dierick Katelijne, Fischer Nathalie, Heyndrickx Leo, Hutse Veronik, Thomas Isabelle, Van Gucht Steven, Vuylsteke Bea, et al. , Lancet Infect Dis, 2021 02, Volume 21, Issue 2, (2021)
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes., Pannus, Pieter, Neven Kristof Y., De Craeye Stéphane, Heyndrickx Leo, Vande Kerckhove Sara, Georges Daphnée, Michiels Johan, Francotte Antoine, Van den Bulcke Marc, Zrein Maan, et al. , Clin Infect Dis, 2021 Dec 03, (2021)
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients., Canti, Lorenzo, Servais Sophie, Ehx Grégory, and Beguin Yves , J Hematol Oncol, 2021 Oct 24, Volume 14, Issue 1, (2021)
Prevalence and incidence of antibodies against SARS-CoV-2 in children and school staff: Main findings of the fourth testing period among primary schoolchildren (Sep-Oct 2021), Merckx, Joanna, Roelants Mathieu, Callies Milena, Kabouche Ines, Desombere I, and Duysburgh Els , (2021)
Prevalence and incidence of antibodies against SARS-CoV-2 in children and school staff measured between December 2020 and June 2021: Findings of the third testing period – brief summary, Merckx, Joanna, Roelants Mathieu, Callies Milena, Kabouche Ines, Desombere I, and Duysburgh Els , (2021)
Prevalence and incidence of antibodies against SARS-CoV-2 in children and school staff measured between December 2020 and June 2021: Findings of the first testing period, Duysburgh, Els, Merckx Joanna, Callies Milena, Kabouche Ines, Vermeulen Melissa, Roelants Mathieu, and Desombere I , 2021, (2021)

QR code

QR code for this page URL